The earnings call highlighted strong revenue and EBITDA growth, alongside strategic initiatives like the pharmacy acquisition showing positive outcomes. However, these were counterbalanced by significant increases in cost of care and administrative expenses, as well as ongoing net losses, indicating financial challenges.

Company Guidance

During the InnovAge Third Quarter 2025 Earnings Conference Call, the company reaffirmed its fiscal 2025 guidance amidst a backdrop of meaningful operational gains and financial improvement. InnovAge reported a revenue of $218.1 million for the quarter, marking a 13% increase year-over-year, with a center-level contribution of $40.7 million, equating to an 18.7% margin. Adjusted EBITDA was reported at $10.8 million, a significant improvement from the $3 million in the third quarter of 2024. The census grew approximately 10% annually to 7,530 participants. The company highlighted its disciplined cost management and effective medical expense control, with external provider costs essentially flat quarter-over-quarter at $107.9 million, and per member per month (PMPM) spending declining to $4,786. InnovAge also focused on strategic initiatives, including transitioning pharmacy services in-house and engaging with policymakers to advocate for the PACE model. The company provided guidance for the fiscal year ending 2025, projecting total revenue between $815 million to $865 million and adjusted EBITDA between $24 million to $31 million, with de novo losses expected to range from $18 million to $20 million.

Revenue Growth

Reported revenue of $218.1 million, marking an approximate 13% increase on a year-over-year basis.

Improved Adjusted EBITDA

Adjusted EBITDA was $10.8 million, a significant improvement from $3 million in the third quarter of 2024.

Census Growth

Census grew to approximately 7,530 participants, an approximate 10% annual increase.

Operational Efficiency

Center-level contribution margin was $40.7 million, representing an 18.7% margin, an improvement of approximately 110 basis points year-over-year.

Pharmacy Initiative Success

Completed the acquisition and integration of a pharmacy in Colorado, improving medication adherence and reducing costs.

InnovAge Holding (INNV) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

Daily Earnings Calendar >

INNV Earnings History

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change	Slides	Play Transcript
Sep 09, 2025	2025 (Q4)	-0.01 / -	-0.01	―	―	―
May 06, 2025	2025 (Q3)	-0.01 / -0.08	-0.04	-100.00% (-0.04)	―
Feb 04, 2025	2025 (Q2)	-0.01 / -0.10	-0.03	-233.33% (-0.07)	―
Nov 05, 2024	2025 (Q1)	-0.04 / -0.04	-0.08	50.00% (+0.04)	―
Sep 10, 2024	2024 (Q4)	-0.02 / -0.01	-0.09	88.89% (+0.08)	―
May 07, 2024	2024 (Q3)	-0.04 / -0.04	-0.05	20.00% (+0.01)	―
Feb 06, 2024	2024 (Q2)	-0.03 / -0.03	-0.07	57.14% (+0.04)	―
Nov 07, 2023	2024 (Q1)	-0.04 / -0.08	-0.1	20.00% (+0.02)	―
Sep 12, 2023	2023 (Q4)	-0.04 / -0.09	-0.09	0.00% (0.00)	―
May 09, 2023	2023 (Q3)	-0.05 / -0.05	-0.02	-150.00% (-0.03)	―

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed

INNV Earnings-Related Price Changes

Report Date	Price 1 Day Before	Price 1 Day After	Percentage Change
May 06, 2025	$2.85	$3.26	+14.39%
Feb 04, 2025	$3.69	$3.36	-8.94%
Nov 05, 2024	$6.07	$6.30	+3.79%
Sep 10, 2024	$6.18	$5.78	-6.47%

Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does InnovAge Holding (INNV) report earnings?

InnovAge Holding (INNV) is schdueled to report earning on Sep 09, 2025, After Close (Confirmed).

What is InnovAge Holding (INNV) earnings time?

InnovAge Holding (INNV) earnings time is at Sep 09, 2025, After Close (Confirmed).

Where can I see when companies are reporting earnings?

You can see which companies are reporting today on our designated earnings calendar.

What companies are reporting earnings today?

You can see a list of the companies which are reporting today on TipRanks earnings calendar.

What is INNV EPS forecast?

INNV EPS forecast for the fiscal quarter 2025 (Q4) is -0.01.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing